- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Sapio Sciences Launches New Molecule Solution Platform
Sapio chemistry solution unifies small-molecule and large-molecule discovery workflows on a single platform.
Sapio Sciences announced the launch of its Sapio chemistry solution, which unifies small-molecule and large-molecule discovery workflows on a single platform. According to the company, the technology enables scientists to draw insights across all their organization’s discovery experiments.
“Many organizations are still running decades-old electronic laboratory notebooks (ELNs) and other software for capturing chemical synthesis experiments and registering small molecules,” said Kevin Cramer, president, CEO, Sapio Sciences. “Large-molecule and small-molecule discovery have traditionally been managed on disparate systems, creating artificial islands that impede scientific collaboration and decision-making. Sapio is excited to give biopharma organizations the opportunity to consolidate all their chemistry experiments on a modern, unified lab platform.”
Reference
Sapio Sciences Unifies Small- and Large-Molecule Discovery on a Single Platform. Business Wire. October 9, 2023. Accessed October 10, 2023. https://www.businesswire.com/news/home/20231009525095/en/Sapio-Sciences-Unifies-Small--and-Large-Molecule-Discovery-on-a-Single-Platform
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
